In this article, we argue for application of the Human Factors Analysis and Classification System (HFACS) to proactive incidence prevention in the public health system response to COVID-19. HFACS is a framework of causal categories of human errors typically applied for systematic retrospective...

Individuals should be entitled to a "fair innings", and the primary role of health systems should be the prevention of premature mortality. In India, 66 percent of all deaths are premature. The burden of premature mortality has shifted from child (0-5 years) to adult (30-69 years) level over the...

This paper examines the effects of globalisation on the pace of governments implementing international travel restrictions during the recent coronavirus pandemic. We find that more globalised countries experienced a longer delay in implementing international travel restriction policies with...

This article investigates how the Swedish population values a reduction in the number of suicides in relation to other life-saving interventions within the health care sector. An online discrete choice experiment was conducted with a sample of 1000 Swedish members of the web panel Userneeds to...

In this paper, we test whether promoting digital government tools increases the take-up of an important public health prevention service: cervical cancer screening. We implemented an at-scale field experiment in Uruguay, randomly encouraging women to make medical appointments with a digital...

We examine the efficiency gains in health systems generated after the national roll out of basic healthcare in El Salvador between 2010 and 2013. Using data from over 120 million consultations and five million hospitalizations, we demonstrate that the expansion of community health teams,...

Today, the global pharmaceutical product value chain is becoming increasingly complex and this has led to the emergence of 'multiple quality standards' for medicines. But this non-uniformity in the quality of medicine is also contingent upon both the regulatory milieu in the country of...

Drug Regulation has been the focus of several recent policy reform efforts in India, starting with the Mashelkar Committee Report in 2003 to the most recent report of the Ranjit Roy Chaudhary Committee in 2013. Nevertheless, the regulatory structure continues to be plagued with several...